Annals of Coloproctology

Original Articles

Minimally invasive surgery

Robotic surgery may lead to reduced postoperative inflammatory stress in colon cancer: a propensity score–matched analysis: Eun Ji Park, Gyong Tae Noh, Yong Joon Lee, Min Young Park, Seung Yoon Yang, Yoon Dae Han, Min Soo Cho, Hyuk Hur, Kang Young Lee, Byung Soh Min; Ann Coloproctol. 2024;40(6):594-601. Published online December 6, 2024; DOI: https://doi.org/10.3393/ac.2024.00171.0024

1,262 View
73 Download
1 Web of Science
1 Citations

Purpose
Robot-assisted surgery is readily applied to every type of colorectal surgeries. However, studies showing the safety and feasibility of robotic surgery (RS) have dealt with rectal cancer more than colon cancer. This study aimed to investigate how technical advantages of RS can translate into actual clinical outcomes that represent postoperative systemic response.
Methods
This study retrospectively reviewed consecutive cases in a single tertiary medical center in Korea. Patients with primary colon cancer who underwent curative resection between 2006 and 2012 were included. Propensity score matching was done to adjust baseline patient characteristics (age, sex, body mass index, American Society of Anesthesiologists physical status, tumor profile, pathologic stage, operating surgeon, surgery extent) between open surgery (OS), laparoscopic surgery (LS), and RS groups.
Results
After propensity score matching, there were 66 patients in each group for analysis, and there was no significant differences in baseline patient characteristics. Maximal postoperative leukocyte count was lowest in the RS group and highest in the OS group (P=0.021). Similar results were observed for postoperative neutrophil count (P=0.024). Postoperative prognostic nutritional index was highest in the RS group and lowest in the OS group (P<0.001). The time taken to first flatus and soft diet resumption was longest in the OS group and shortest in the RS group (P=0.001 and P<0.001, respectively). Among all groups, other short-term postoperative outcomes such as hospital stay and complications did not show significant difference, and oncological survival results were similar.
Conclusion
Better postoperative inflammatory indices in the RS group may correlate with their faster recovery of bowel motility and diet resumption compared to LS and OS groups.

Citations

Citations to this article as recorded by

Übergangsphase zur roboterassistierten Chirurgie beim kolorektalen Karzinom: eine vergleichende konsekutive Kohortenstudie
U. A. Dietz, M. Kalisvaart, S. Maksimovic, R. Frey, M. Ramser, B. M. Erhart, U. Pfefferkorn
Die Chirurgie.2025;[Epub] CrossRef

Colorectal cancer

Long-term bowel functional outcomes following anal sphincter-preserving surgery for upper and middle rectal cancer: a single-center longitudinal study: Ahmad Sakr, Seung Yoon Yang, Min Soo Cho, Hyuk Hur, Byung Soh Min, Kang Young Lee, Nam Kyu Kim; Ann Coloproctol. 2024;40(1):27-35. Published online February 28, 2024; DOI: https://doi.org/10.3393/ac.2022.01067.0152

2,791 View
197 Download
2 Web of Science
2 Citations

Abstract PDF

Purpose
Despite advances in neoadjuvant chemoradiotherapy and anal sphincter-preserving surgery for rectal cancer, bowel dysfunction is still unavoidable and negatively affects patients’ quality of life. In this longitudinal study, we aimed to investigate the changes in bowel function with follow-up time and the effect of neoadjuvant chemoradiotherapy on bowel function following low anterior resection for rectal cancer.
Methods
In this study, 171 patients with upper or middle rectal cancer who underwent low anterior resection between 2012 and 2018 were included. Bowel function was assessed longitudinally with Memorial Sloan Kettering Cancer Center Bowel Function Instrument and Wexner scores every 6 months after restoration of bowel continuity. Patients with at least 2 follow-up visits were included.
Results
Overall, 100 patients received neoadjuvant chemoradiotherapy. Urgency, soilage, and fecal incontinence were noted within 24 months in the patients treated with neoadjuvant chemoradiotherapy. After 2 years of follow-up, significant bowel dysfunction and fecal incontinence were observed in the neoadjuvant chemoradiotherapy group. Low tumor level and neoadjuvant chemoradiotherapy were associated with delayed bowel dysfunction.
Conclusion
Neoadjuvant chemoradiotherapy in combination with low tumor level was significantly associated with delayed bowel dysfunction even after 2 years of follow-up. Therefore, careful selection and discussion with patients are paramount.

Citations

Citations to this article as recorded by

Efficacy of Neoadjuvant Hypofractionated Chemoradiotherapy in Elderly Patients with Locally Advanced Rectal Cancer: A Single-Center Retrospective Analysis
Jae Seung Kim, Jaram Lee, Hyeung-min Park, Soo Young Lee, Chang Hyun Kim, Hyeong Rok Kim
Cancers.2024; 16(24): 4280. CrossRef
Beyond survival: a comprehensive review of quality of life in rectal cancer patients
Won Beom Jung
Annals of Coloproctology.2024; 40(6): 527. CrossRef

Impact of Adjuvant Chemotherapy Completion on Oncologic Outcomes in ypTNMstage 2 Rectal Cancer Patients: Youn Young Park, Kang Young Lee, Nam Kyu Kim, Sat Byol Lee, Ga Ram Kim, Byung Soh Min, Seong-Taek Oh; Ann Coloproctol. 2019;35(6):335-341. Published online December 31, 2019; DOI: https://doi.org/10.3393/ac.2019.03.10

3,932 View
63 Download
2 Web of Science
2 Citations

Abstract PDF

Purpose
Adjuvant chemotherapy (aCT) in rectal cancer patients who have undergone curative resection after neoadjuvant chemoradiation (nCRT) is controversial. We aimed to investigate the benefits of using aCT and the clinical impact of completing aCT in ypstage 2 rectal cancer patients.
Methods
We retrospectively reviewed clinicopathological data from patients who had undergone radical resection after nCRT between January 2006 and December 2012. In total, 152 patients with ypT3/4N0M0 rectal cancer were included. Of these patients, 139 initiated aCT, while 13 did not receive aCT (no-aCT). Among those who received aCT, 132 patients completed their planned cycles (aCT-completion) whereas 7 did not (aCT-incompletion). All patients received longcourse chemoradiation; a 5-fluorouracil-based regimen was used for nCRT in most patients. The prognostic factors affecting disease-free survival (DFS) and overall survival (OS) were analyzed.
Results
The median follow-up duration was 41 months. Demographic data did not differ significantly among the 3 groups. In multivariate analysis, open surgery, a tumor size >2 cm, retrieval of <12 lymph nodes, circumferential resection margin (CRM) positivity and aCT incompletion were independent prognostic factors for poor DFS. Old age (≥60 years), open surgery, CRM positivity, aCT incompletion, and lack of aCT initiation compared to aCT completion were independent prognostic factors for poor OS.
Conclusion
In ypstage 2 rectal cancer patients, aCT after nCRT and total mesorectal excision affected both DFS and OS; however, only patients who completed planned aCT exhibited survival benefits. Therefore, improving patients’ compliance with the completion of aCT is desirable.

Citations

Citations to this article as recorded by

Adjuvant chemotherapy in locally advanced rectal cancer after neo-adjuvant concurrent chemoradiotherapy and surgery: A retrospective study in Vietnamese patients
Thang Tran, Huy Van Nguyen, Hoa Thi Nguyen, Hung Van Nguyen
Annals of Medicine & Surgery.2023; 85(9): 4234. CrossRef
Watch and wait strategies for rectal cancer: A systematic review
In Ja Park
Precision and Future Medicine.2022; 6(2): 91. CrossRef

Short-term Outcomes After Upfront Chemotherapy Followed by Curative Surgery in Metastatic Colon Cancer: A Comparison With Upfront Surgery Patients: Myung Hyun Han, Youn Young Park, Shiva Pratap, Yoon Dae Han, Min Soo Cho, Hyuk Hur, Byung Soh Min, Kang Young Lee, Nam Kyu Kim; Ann Coloproctol. 2019;35(6):327-334. Published online December 31, 2019; DOI: https://doi.org/10.3393/ac.2019.03.04.1

3,704 View
70 Download
2 Web of Science
2 Citations

Abstract PDF

Purpose
Upfront systemic chemotherapy with target agents has been recommended for patients with stage IV colon cancer. Some with partial response are considered for curative resection. There is high risk of developing postoperative complications following upfront systemic chemotherapy. We aimed to evaluate short-term perioperative outcomes of curative surgery after upfront chemotherapy in comparison with upfront surgery in patients with metastatic colon cancer.
Methods
Between January 2010 and October 2015, 146 patients (80 in the surgery first group, 66 in the upfront chemotherapy group) who underwent surgical resection before or after systemic chemotherapy for metastatic colon cancer were included in the present study. All decisions for treatment were made through a multidisciplinary team. Postoperative clinical outcomes and complications were analyzed to compare the groups.
Results
There was no difference between the 2 groups in terms of postoperative clinical outcomes. Overall complication rates were not different between the groups (surgery first group: 46.3% vs. upfront chemotherapy group: 60.6%; P = 0.084). When classified according to the Clavien-Dindo method, there was no difference between the 2 groups in terms of major complications (grade 3 or more) (surgery first group: 18.9% vs. upfront chemotherapy group: 27.5%; P = 0.374).
Conclusion
There was no significant increase in major postoperative complications in metastatic colon cancer patients who received upfront chemotherapy followed by curative surgery. Careful patient selection and treatment planning are important.

Citations

Citations to this article as recorded by

Impact of preoperative chemotherapy on perioperative morbidity in combined resection of colon cancer and liver metastases
Joy Z. Done, Angelos Papanikolaou, Miloslawa Stem, Shannon N. Radomski, Sophia Y. Chen, Chady Atallah, Jonathan E. Efron, Bashar Safar
Journal of Gastrointestinal Surgery.2023; 27(11): 2380. CrossRef
Treatment for Peritoneal Metastasis of Patients With Colorectal Cancer
Young Jin Kim, Chang Hyun Kim
Annals of Coloproctology.2021; 37(6): 425. CrossRef

Single-center Experience of 24 Cases of Tailgut Cyst: Ahmad Sakr, Ho Seung Kim, Yoon Dae Han, Min Soo Cho, Hyuk Hur, Byung Soh Min, Kang Young Lee, Nam Kyu Kim; Ann Coloproctol. 2019;35(5):268-274. Published online October 31, 2019; DOI: https://doi.org/10.3393/ac.2018.12.18

11,037 View
289 Download
34 Web of Science
47 Citations

Abstract PDF

Purpose
Tailgut cysts are rare congenital or developmental lesions that arise from vestiges of the embryological hindgut. They are usually present in the presacral space. We report our single-center experience with managing tailgut cysts.
Methods
We conducted a retrospective analysis of 24 patients with tailgut cyst treated surgically at the Colorectal Surgery Department of Severance Hospital, Yonsei University, Seoul, South Korea, between 2007–2018.
Results
This study included 24 patients (18 females) with a median age of 51.5 years (range, 21–68 years). Ten cases were symptomatic and 14 were asymptomatic. Cysts were retrorectal in 21 patients. Cysts were below the coccyx level in 16 patients, opposite the coccyx in 6, and above the coccyx in 2. Cysts were supralevator in 5 patients, had a supra- and infralevator extension in 18 patients, and were infralevator in 1. Ten patients were managed using an anterior laparoscopic approach, 11 using a posterior approach, and 3 using a combined approach. Mean cyst size was 5.5 ± 2.7 cm. Postoperative complications were Clavien-Dindo (CD) classification grade II in 9 patients (37.5%) and CD grade III in 1 (4.2%). The posterior approach group showed the highest rate of complications (P = 0.021). Patients managed using a combined approach showed a larger cyst size (P < 0.001), longer operation times (P < 0.001), and a greater likelihood of tumor level above the coccyx (P = 0.002) compared to other approaches. The tumors of 2 male patients were malignant: 1 was a neuroendocrine tumor treated with radiotherapy, while the other was a closely followed adenocarcinoma. Median follow-up was 12 months (range, 1–66 months) with no recurrence.
Conclusion
Tailgut cysts are uncommon but can cause perineal or pelvic pain. Complete surgical excision via an appropriate approach according to tumor size, location, and correlation with adjacent pelvic floor muscles is the key treatment.

Citations

Citations to this article as recorded by

Risk factors for rectal perforation during presacral cyst removal: a comparison between transabdominal, perineal, and combined surgical approaches
P. Tsarkov, S. Barkhatov, D. Shlyk, L. Safyanov, V. Balaban, M. He
Techniques in Coloproctology.2025;[Epub] CrossRef
Tailgut Cyst—Gynecologist’s Pitfall: Literature Review and Case Report
Andrei Mihai Malutan, Viorela-Elena Suciu, Florin Laurentiu Ignat, Doru Diculescu, Razvan Ciortea, Emil-Claudiu Boțan, Carmen Elena Bucuri, Maria Patricia Roman, Ionel Nati, Cristina Ormindean, Dan Mihu
Diagnostics.2025; 15(1): 108. CrossRef
Laparoscopic Excision of a Tailgut Cyst With Refractory Pain: A Case Report
Masato Kitazawa, Seishu Karasawa, Satoshi Nakamura, Yuta Yamamoto, Yuji Soejima
Cureus.2025;[Epub] CrossRef
Diagnostic challenges of tailgut cysts: a case report on an occult perianal mass
Faraz Khalid, Haris Naveed, Masab Ali, Muhammad Saad Ansari, Muhammad Sajjad Shafiq, Muhammad Husnain Ahmad
Annals of Medicine & Surgery.2025; 87(1): 421. CrossRef
Transanal-transrektale endoskopische Resektion einer Schwanzdarmzyste
Hussein Abdallah, Stefan Heinrich, Matthias Birth
coloproctology.2025; 47(3): 220. CrossRef
Partial Resection of a Tailgut Cyst Attached to the Rectum via a Transcoccygeal Approach: A Case Report With a Favorable Outcome
Eitaro Okumura, Motoo Kubota, Ouji Momosaki, Ryo Hashimoto, Kotaro Kohara
Cureus.2025;[Epub] CrossRef
Recurrent presacral tailgut cyst with mucinous adenocarcinoma and metastasis
Iyad Al Jada, Majd Oweidat, Mohammad Khaleel, Omar Harb, Ursula Abu Nahla, Rahaf Bleibel, Mai Arafeh, Ammar W.M. Hassouneh
Radiology Case Reports.2025; 20(8): 4022. CrossRef
Trans‐abdominal single‐incision robotic surgery with the da Vinci SP® surgical system for 8 cases of retrorectal tumour
Ho Seung Kim, Bo‐Young Oh, Soon Sup Chung, Ryung‐Ah Lee, Gyoung Tae Noh
The International Journal of Medical Robotics and Computer Assisted Surgery.2024;[Epub] CrossRef
Three Cases of Anal Cystic Lesions in Our Hospital
Kaori Tanaka, Toshiharu Mori, Hideki Yamada, Hideki Mori
Nihon Daicho Komonbyo Gakkai Zasshi.2024; 77(4): 199. CrossRef
Diagnosis and treatment of retrorectal cystic hamartoma: clinical case
S. A. Zvezda, D. G. Dimitriadi, P. I. Tamrazov, A. V. Simonov, E. M. Frank, N. M. Fedorov, L. N. Komarova
Surgery and Oncology.2024; 14(1): 72. CrossRef
Presacral Tailgut Cyst
Shriya Haval, Divyansh Dwivedi, Prabhat Nichkaode
Annals of African Medicine.2024; 23(2): 237. CrossRef
A neuroendocrine tumor arising in a tailgut cyst: Case report and literature review
Wei Guo, Ming Deng, Qiongrong Chen
International Journal of Surgery Case Reports.2024; 120: 109912. CrossRef
Tailgut Cyst in a Child: A Case Report and Review of Literature
Ramendra Shukla, Jay Divyesh Patel, Sudhir B. Chandna, Urvish Parikh
African Journal of Paediatric Surgery.2024; 21(3): 184. CrossRef
Two Cases of Symptomatic Tailgut Cysts
Jan Wojciechowski, Tomasz Skołozdrzy, Piotr Wojtasik, Maciej Romanowski
Journal of Clinical Medicine.2024; 13(17): 5136. CrossRef
The management of retrorectal tumors – a single-center analysis of 21 cases and overview of the literature
K. Fechner, B. Bittorf, M. Langheinrich, K. Weber, M. Brunner, R. Grützmann, K. E. Matzel
Langenbeck's Archives of Surgery.2024;[Epub] CrossRef
Kraske-Zugang für Tumoren im kaudalen retrorektalen Raum
Rosita Sortino, Sebastian Christen, Daniel Steinemann, Ida Füglistaler
coloproctology.2024; 46(6): 413. CrossRef
Laparoscopic approach in the surgical treatment of large retrorectal tumors: a short-term experience at a single tertiary center case series in Korea
Jun Seong Chung, Han Deok Kwak, Jae Kyun Ju
Journal of Minimally Invasive Surgery.2024; 27(4): 221. CrossRef
Open surgical treatment for giant presacral tailgut cyst – a case report
Q Liu, P Guo, C Li, G Yu, J Jiao
South African Journal of Surgery.2024; 62(4): 358. CrossRef
Cystic lesions of the retrorectal space
Ian S Brown, Anna Sokolova, Christophe Rosty, Rondell P Graham
Histopathology.2023; 82(2): 232. CrossRef
Tailgut cyst mimicking second anal opening in an infant
Jay Lodhia, Mujaheed Suleman, Doreen Msemakweli, Joshua Tadayo, Patrick Amsi, David Msuya
Journal of Pediatric Surgery Case Reports.2023; 89: 102550. CrossRef
Surgery of presacral cysts: case series analysis and literature review
K. V. Stegnii, Zh. A. Rakhmonov, R. A. Goncharuk, M. A. Krekoten, E. R. Dvoinikova, E. V. Morova, M. О. Dmitriev
Pacific Medical Journal.2023; (2): 15. CrossRef
Surgical treatment of retrorectal tumors: a plea for a laparoscopic approach
Clara Galán, M. Pilar Hernández, M. Carmen Martínez, Anna Sánchez, Jesús Bollo, Eduardo Mª Targarona
Surgical Endoscopy.2023; 37(12): 9080. CrossRef
Robotic approach to remove four tailgut cyst cases in Brazil: a case series
Bruno Mirandola Bulisani, Luiz Guilherme Lisboa Gomes, Milena Arruda de Oliveira Leite, Ricardo Moreno, Murilo Rocha Rodrigues, Felipe Martin Bianco Rossi, Renato Barretto Ferreira da Silva, Luiz Carlos Benjamin do Carmo, Jaques Waisberg
einstein (São Paulo).2023;[Epub] CrossRef
Tumor neuroendocrino asociado con quiste intestinal: presentación de un caso
Lismary Ruiz Cabezas, Alicia Moreno Ontalba, Mario Díaz Delgado, Esther María Cidoncha Pérez, Alejandro Rubio Fernández, María Victoria González Ibáñez
Revista Española de Patología.2022; 55(4): 278. CrossRef
Risk of malignancy and outcomes of surgically resected presacral tailgut cysts: A current review of the Mayo Clinic experience
Sacha P. Broccard, Dorin T. Colibaseanu, Kevin T. Behm, Nitin Mishra, Peter Davis, Kristi L. Maimone, Kellie L. Mathis, Luca Stocchi, Eric J. Dozois, Amit Merchea
Colorectal Disease.2022; 24(4): 422. CrossRef
Squamous cell carcinoma in a retrorectal cystic hamartoma
Quintáns Ana Teijo, Valadés José Ignacio Martín , del Río Cristina Garrán , Rojo Irene López , Casado Oscar Alonso
Journal of Radiology and Oncology.2022; 6(1): 001. CrossRef
Retrorectal Tailgut Cyst: A Case Report
Neel Shah, Peter Edelstein
Cureus.2022;[Epub] CrossRef
A Case of Tailgut Cyst Treated with Laparoscopic Transabdominal and Transsacral Surgery
Naoki Kawahara, Yoshiyuki Suzuki, Yu Sakai, Shinji Maeshima, Takehiro Shimada
Nippon Daicho Komonbyo Gakkai Zasshi.2022; 75(4): 170. CrossRef
Promoting Laparoscopic Anterior Approach for a Very Low Presacral Primary Neuroendocrine Tumor Arising in a Tailgut Cyst
Maria Michela Di Nuzzo, Carlo De Werra, Mirella Pace, Raduan Ahmed Franca, Maria D’Armiento, Umberto Bracale, Ruggero Lionetti, Michele D’Ambra, Armando Calogero
Healthcare.2022; 10(5): 805. CrossRef
A Case of Dermoid Cyst in the Ischiorectal Fossa Resected by the Transperineal Approach
Susumu Daibo, Hirokazu Suwa, Seiya Sato, Koki Goto, Yusuke Suwa, Jun Watanabe
Nippon Daicho Komonbyo Gakkai Zasshi.2022; 75(5): 237. CrossRef
Perianal Tailgut Cyst: An Unusual Presentation
Rabia Arshad, Noor Khalid, Mubashir Rafique, Ruqia Mushtaq, Fakhar Munir Sial
Cureus.2022;[Epub] CrossRef
Squamous cell carcinoma arising in a tailgut cyst: role of radiotherapy
Diego Aldave, Ana Teijo, Claudia Abril, Laura Cerezo
BMJ Case Reports.2022; 15(9): e247985. CrossRef
Hamartoma quístico retrorrectal (tailgut cyst): reporte de un caso y revisión de la literatura
Juan Dario Puerta Diaz, Rodrigo Castaño Llano, Alfredo Enrique Martelo Román, Juan Esteban Puerta Botero
Revista colombiana de Gastroenterología.2022; 37(3): 316. CrossRef
Diagnostic, Therapeutic and Evolutionary Problems of Retro-Rectal Tumors (About 3 Cases)
Hajri Amal, Ahmed Elmi Abdirahim, Rachid Boufettal, Erguibi Driss, Saad Rifki El Jai, Farid Chehab
European Journal of Medical and Health Sciences.2022; 4(5): 13. CrossRef
Epidemiology, diagnostic approach and therapeutic management of tailgut cysts: A systematic review
Aikaterini Mastoraki, Ilias Giannakodimos, Karmia Panagiotou, Maximos Frountzas, Dimosthenis Chrysikos, Stylianos Kykalos, Georgios E. Theodoropoulos, Dimitrios Schizas
International Journal of Clinical Practice.2021;[Epub] CrossRef
Re: Malignant transformation of tailgut cysts is significantly higher than previously reported: Systematic review of cases in the literature
Tamara Glyn, Peter Sagar, Frank Frizelle
Colorectal Disease.2021; 23(11): 3027. CrossRef
Multicenter Analysis of Presacral Neuroendocrine Neoplasms—Clinicopathological Characterization and Treatment Outcomes of a Rare Disease
Sami Matrood, Leonidas Apostolidis, Jörg Schrader, Sebastian Krug, Harald Lahner, Annette Ramaswamy, Damiano Librizzi, Zoltan Kender, Anke Kröcher, Simon Kreutzfeldt, Thomas Matthias Gress, Anja Rinke
Frontiers in Endocrinology.2021;[Epub] CrossRef
Surgical Management of Retrorectal Tumors
Mathilde Aubert, Diane Mege, Yann Parc, Eric Rullier, Eddy Cotte, Guillaume Meurette, Philippe Zerbib, Bertrand Trilling, Bernard Lelong, Charles Sabbagh, Zaher Lakkis, Mehdi Ouaissi, Gil Lebreton, Philippe Rouanet, Gilles Manceau, Jean-Jacques Tuech, Gui
Annals of Surgery.2021; 274(5): 766. CrossRef
Isolated lumbar intradural tailgut cyst: A case report and review of the literature
Antonio Colamaria, Matteo Sacco, Giovanni Parbonetti, Maria Blagia, Francesco Carbone, Matteo de Notaris
Heliyon.2021; 7(10): e08223. CrossRef
Prerectal tailgut cyst presenting with constipation and pseudo-rectal prolapse. A rare case presentation
Allan Ngulube, Blessing Zambuko, Crispin O.M. Ntoto, Simbarashe Gift Mungazi, Derek Matsika
Human Pathology Reports.2021; 26: 300557. CrossRef
Anal Canal Duplication in an Adult Female—Case Report and Pathology Guiding
Tudor Mateescu, Cristi Tarta, Paul Stanciu, Alis Dema, Fulger Lazar
Medicina.2021; 57(11): 1205. CrossRef
“The Innate Tail”: An Unusual Cause of Rectal Bleeding in an Adult Male
Sujit Padmanabhan Nair, Sanjay Chandnani, Prasanta Debnath, Pravin M. Rathi, Parmeshwar Junare, Vinay Zanwar, Sangeeta Kini
GE - Portuguese Journal of Gastroenterology.2021; 28(5): 349. CrossRef
Robotic approach to large tailgut cyst with malignant transformation: A case report
Alessandra Marano, Maria Carmela Giuffrida, Chiara Peluso, Valentina Testa, Paolo Bosio, Felice Borghi
International Journal of Surgery Case Reports.2020; 77: S57. CrossRef
Laparoscopic resection of a neuroendocrine tumor that almost fully replaced tailgut cysts: a case report
Keita Kodera, Seiichiro Eto, Nei Fukasawa, Wataru Kai, Tomo Matsumoto, Tsuyoshi Hirabayashi, Hidejiro Kawahara, Nobuo Omura
Surgical Case Reports.2020;[Epub] CrossRef
Retrorectal tumors: Case report and review of literature
Giorgio La Greca, Giovanni Trombatore, Guido Basile, Pietro Conti
International Journal of Surgery Case Reports.2020; 77: 726. CrossRef
A Tailgut Cyst in the Ischiorectal Fossa—A Case Report—
Ryo INADA, Eri KURODA, Ayako WATANABE, Toshiaki TOSHIMA, Kazuhide OZAKI, Yuichi SHIBUYA, Manabu MATSUMOTO, Jun IWATA
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association).2020; 81(9): 1866. CrossRef
Tailgut Cyst, Report of 24 Cases Single Center Experience
Han Deok Kwak, Chang Hyun Kim
Annals of Coloproctology.2019; 35(5): 227. CrossRef

Laparoscopic and Robotic Surgeries for Patients With Colorectal Cancer Who Have Had a Previous Abdominal Surgery: Soeun Park, Jeonghyun Kang, Eun Jung Park, Seung Hyuk Baik, Kang Young Lee; Ann Coloproctol. 2017;33(5):184-191. Published online October 31, 2017; DOI: https://doi.org/10.3393/ac.2017.33.5.184

5,312 View
70 Download
12 Web of Science
14 Citations

Abstract PDF

Purpose

The impact of previous abdominal surgery (PAS) on surgical outcomes from laparoscopic and robot surgeries is inconclusive. This study aimed to investigate the impact of PAS on perioperative outcomes from laparoscopic and robotic colorectal surgeries.

Methods

From March 2007 to February 2014, a total of 612 and 238 patients underwent laparoscopic and robotic surgeries, respectively. Patients were divided into 3 groups: those who did not have a PAS (NPAS), those who had a major PAS, and those who had a minor PAS. We further divided the patients so that our final groups for analysis were: patients with NPAS (n = 478), major PAS (n = 19), and minor PAS (n = 115) in the laparoscopy group, and patients with NPAS (n = 202) and minor PAS (n = 36) in the robotic surgery group.

Results

In the laparoscopy group, no differences in the conversion rates between the 3 groups were noted (NPAS = 1.0% vs. major PAS = 0% vs. minor PAS = 1.7%, P = 0.701). In the robotic surgery group, the conversion rate did not differ between the NPAS group and the minor PAS group (1.0% vs. 2.8%, P = 0.390). Among the groups, neither the operation time, blood loss, days to soft diet, length of hospital stay, nor complication rate were affected by PAS.

Conclusion

PAS did not jeopardize the perioperative outcomes for either laparoscopic or robotic colorectal surgeries. Therefore, PAS should not be regarded as an absolute contraindication for minimally invasive colorectal surgeries.

Citations

Citations to this article as recorded by

Robotic-assisted versus laparoscopic surgery for colorectal cancer in high-risk patients: a systematic review and meta-analysis
S. Gahunia, J. Wyatt, S. G. Powell, S. Mahdi, S. Ahmed, K. Altaf
Techniques in Coloproctology.2025;[Epub] CrossRef
Impact of previous abdominal surgery on minimally invasive radical resection of colorectal cancer: A meta-analysis
Wenjun Liu, Fan He, Defei Chen, Xiuping Zhang
European Journal of Surgical Oncology.2025; : 110259. CrossRef
Effect of previous abdominal surgery on robotic-assisted rectal cancer surgery
Davide Ferrari, Tommaso Violante, Himani Bhatt, Ibrahim A. Gomaa, Anne-Lise D. D’Angelo, Kellie L. Mathis, David W. Larson
Journal of Gastrointestinal Surgery.2024; 28(4): 513. CrossRef
The impact of previous abdominal surgery on colorectal cancer patients undergoing laparoscopic surgery
Xu-Rui Liu, Bing-Lan Zhang, Dong Peng, Fei Liu, Zi-Wei Li, Chun-Yi Wang
Updates in Surgery.2024; 76(4): 1331. CrossRef
Robot‐assisted radical cystectomy for bladder cancer after low anterior resection: A case report
Shoutarou Watanabe, Hiroaki Kobayashi, Nao Hiroe, Tomohiro Iwasawa, Michio Kosugi, Masayuki Shimizu, Masaru Ishida
Asian Journal of Endoscopic Surgery.2024;[Epub] CrossRef
The risk of postoperative complications is higher in stage I-III colorectal cancer patients with previous abdominal surgery: a propensity score matching analysis
Xu-Rui Liu, Fei Liu, Zi-Wei Li, Xiao-Yu Liu, Wei Zhang, Dong Peng
Clinical and Translational Oncology.2023; 25(12): 3471. CrossRef
Pretreatment inflammatory markers predicting treatment outcomes in colorectal cancer
Sanghyun An, Hongjin Shim, Kwangmin Kim, Bora Kim, Hui-Jae Bang, Hyejin Do, Hyang-Rae Lee, Youngwan Kim
Annals of Coloproctology.2022; 38(2): 97. CrossRef
Current status of robotic surgery for colorectal cancer: A review
Won Beom Jung
International Journal of Gastrointestinal Intervention.2022; 11(2): 56. CrossRef
Conversions related to adhesions in abdominal surgery. Robotic versus laparoscopic approach: A multicentre experience
Marco Milone, Nicola de'Angelis, Nassiba Beghdadi, Francesco Brunetti, Michele Manigrasso, Giuseppe De Simone, Giuseppe Servillo, Sara Vertaldi, Giovanni Domenico De Palma
The International Journal of Medical Robotics and Computer Assisted Surgery.2021;[Epub] CrossRef
Robotic and laparoscopic liver resection—comparative experiences at a high-volume German academic center
E. Lorenz, J. Arend, M. Franz, M. Rahimli, A. Perrakis, V. Negrini, A. A. Gumbs, R. S. Croner
Langenbeck's Archives of Surgery.2021; 406(3): 753. CrossRef
Robotic versus Laparoscopic Colorectal Surgeries
Anil Heroor, Aysha Khan, Kashish Jain, Akshay Patil, Hitesh Rajendra Singhavi
Indian Journal of Colo-Rectal Surgery.2021; 4(1): 12. CrossRef
Safety and feasibility of repeat laparoscopic colorectal resection: a matched case–control study
Alban Zarzavadjian le Bian, Laurent Genser, Christine Denet, Carlotta Ferretti, Anais Laforest, Jean-Marc Ferraz, Candice Tubbax, Philippe Wind, Brice Gayet, David Fuks
Surgical Endoscopy.2020; 34(5): 2120. CrossRef
Impact of previous abdominal surgery on robotic-assisted rectal surgery in patients with locally advanced rectal adenocarcinoma: a propensity score matching study
Ching-Wen Huang, Wei-Chih Su, Tsung-Kun Chang, Cheng-Jen Ma, Tzu-Chieh Yin, Hsiang-Lin Tsai, Po-Jung Chen, Yen-Cheng Chen, Ching-Chun Li, Yi-Chien Hsieh, Jaw-Yuan Wang
World Journal of Surgical Oncology.2020;[Epub] CrossRef
An individualized laparoscopic‐assisted approach in a patient with a sigmoid tumour and a giant incisional hernia – a video vignette
C. Clancy, M. Flanagan, M. Bughio, M. G. O'Riordain
Colorectal Disease.2019; 21(8): 972. CrossRef

Single Center Experience With Hyperthermic Intraperitoneal Chemotherapy: Woo Ram Kim, Hyuk Hur, Byung Soh Min, Seung Hyuk Baik, Kang Young Lee, Nam Kyu Kim; Ann Coloproctol. 2017;33(1):16-22. Published online February 28, 2017; DOI: https://doi.org/10.3393/ac.2017.33.1.16

4,717 View
73 Download
6 Web of Science
4 Citations

Abstract PDF

Purpose

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been proposed for controlling peritoneal seeding metastasis in some kinds of cancers, including those of colorectal origin, but their safety and oncological benefits are subjects of debate. We present our early experience with those procedures.

Methods

Data were retrospectively collected from all patients with peritoneal carcinomatosis (PC) and pseudomyxoma peritonei (PMP) treated using CRS and HIPEC at Yonsei Cancer Center between July 2014 and July 2015. Short-term outcomes and risk factors for postoperative complications were analyzed.

Results

Twenty-three patients with PC (n = 18) and PMP (n = 5) underwent CRS and HIPEC. Median follow-up and age were 2 months and 54 years, respectively. The median peritoneal carcinomatosis index score was 15, and CC0-1 was achieved in 78.3% of all patients. The median operation time and bleeding loss were 590 minutes and 570 mL, respectively. Grade-IIIa/grade-IIIb complications occurred in 4.3% (n = 1)/26.1% (n = 6) of the patients within 30 days postoperatively, and no 30-day mortalities were reported. Factors related to postoperative complications with CRS and HIPEC were number of organ resection (P = 0.013), longer operation time (P < 0.001), and amount of blood loss (P = 0.003). All patients treated with cetuximab for recurred colorectal cancer had grade-III postoperative complication.

Conclusion

Our initial experience with CRS and HIPEC presented about 30% grade-III postoperative complications. Therefore, expert surgeons need to perform those procedures with great caution in selected patients who might benefit from it.

Citations

Citations to this article as recorded by

Multisocietal Consensus on the Use of Cytoreductive Surgery and HIPEC for the Treatment of Diffuse Malignant Peritoneal Mesothelioma: A GRADE Approach for Evidence Evaluation and Recommendation
Shigeki Kusamura, Michela Cinquini, David Morris, Pompiliu Piso, Hedy Kindler, Andreas Brandl, Edward Levine, Olivier Glehen, Vahan Kepenekian, Olivia Sgarbura, Paul H. Sugarbaker, Dario Baratti, Guaglio Marcello, Deraco Marcello
Journal of Surgical Oncology.2025; 131(5): 810. CrossRef
Pharmacologic Effects of Oxaliplatin Instability in Chloride-Containing Carrier Fluids on the Hyperthermic Intraperitoneal Chemotherapy to Treat Colorectal Cancer In Vitro and In Vivo
Eun Jung Park, Junhyun Ahn, Sharif Md Abuzar, Kyung Su Park, Sung-Joo Hwang, Seung Hyuk Baik
Annals of Surgical Oncology.2022; 29(13): 8583. CrossRef
Treatment for Peritoneal Metastasis of Patients With Colorectal Cancer
Young Jin Kim, Chang Hyun Kim
Annals of Coloproctology.2021; 37(6): 425. CrossRef
Is Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy a Safe and Effective Procedure for Treating Patients With a Peritoneal Surface Malignancy?
Dong-Guk Park
Annals of Coloproctology.2017; 33(1): 3. CrossRef

Prognostic Impact of Immunonutritional Status Changes During Preoperative Chemoradiation in Patients With Rectal Cancer: Yong Joon Lee, Woo Ram Kim, Jeonghee Han, Yoon Dae Han, Min Soo Cho, Hyuk Hur, Kang Young Lee, Nam Kyu Kim, Byung Soh Min; Ann Coloproctol. 2016;32(6):208-214. Published online December 31, 2016; DOI: https://doi.org/10.3393/ac.2016.32.6.208

4,872 View
57 Download
18 Web of Science
14 Citations

Abstract PDF

Purpose

Previous studies have demonstrated the prognostic impact of the prognostic nutritional index (PNI), a proposed indicator of immunonutritional statuses of surgical patients, on patients with various gastrointestinal cancers. Although the prognostic impact of the PNI on patients with colorectal cancer has been well established, its value has not been studied in patients treated with preoperative chemoradiation (pCRT). This study aimed to evaluate the prognostic impact of PNI on patients receiving pCRT for locally advanced rectal cancer (LARC).

Methods

Patients with LARC who underwent curative pCRT followed by surgical resection were enrolled. The PNI was measured in all patients before and after pCRT, and the difference in values was calculated as the PNI difference (dPNI). Patients were classified according to dPNI (<5, 5–10, and >10). Clinicopathologic parameters and long-term oncologic outcomes were assessed according to dPNI classification.

Results

No significant intergroup differences were observed in clinicopathologic parameters such as age, histologic grade, tumor location, tumor-node-metastasis stage, and postoperative complications. Approximately 53% of the patients had a mild dPNI (<5); only 15% had a high dPNI (>10). Univariate and multivariate analyses identified the dPNI as an independent prognostic factor for disease-free status (P < 0.01; hazard ratio [HR], 2.792; 95% confidence interval [CI], 1.577–4.942) and for cancer-specific survival (P = 0.012; HR, 2.469; 95%CI, 1.225–4.978).

Conclusion

The dPNI is predictive of long-term outcomes in pCRT-treated patients with LARC. Further prospective studies should investigate whether immune-nutritional status correction during pCRT would improve oncologic outcomes.

Citations

Citations to this article as recorded by

Preoperative albumin-to-globulin ratio and prognostic nutritional index predict the prognosis of colorectal cancer: a retrospective study
JunHu Li, Na Zhu, Cheng Wang, LiuPing You, WenLong Guo, ZhiHan Yuan, Shuai Qi, HanZheng Zhao, JiaYong Yu, YueNan Huang
Scientific Reports.2023;[Epub] CrossRef
The modified Glasgow prognostic score is a reliable predictor of oncological outcomes in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy
Atsushi Shimada, Takeru Matsuda, Ryuichiro Sawada, Hiroshi Hasegawa, Kimihiro Yamashita, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Shingo Kanaji, Taro Oshikiri, Yoshihiro Kakeji
Scientific Reports.2023;[Epub] CrossRef
Prognostic Value of Postoperative Neutrophil and Albumin: Reassessment One Month After Gastric Cancer Surgery
Ali Guner, Minah Cho, Yoo-Min Kim, Jae-Ho Cheong, Woo Jin Hyung, Hyoung-Il Kim
Frontiers in Oncology.2021;[Epub] CrossRef
Pelvimetric and Nutritional Factors Predicting Surgical Difficulty in Laparoscopic Resection for Rectal Cancer Following Preoperative Chemoradiotherapy
Yanwu Sun, Jianhua Chen, Chengwei Ye, Huiming Lin, Xingrong Lu, Ying Huang, Pan Chi
World Journal of Surgery.2021; 45(7): 2261. CrossRef
Inflammation‐nutritional markers of peripheral blood could predict survival in advanced non‐small‐cell lung cancer patients treated with PD‐1 inhibitors
Dan Pu, Qian Xu, Lai‐Yan Zhou, Yu‐Wen Zhou, Ji‐Yan Liu, Xue‐Lei Ma
Thoracic Cancer.2021; 12(21): 2914. CrossRef
Preoperative change of modified Glasgow prognostic score after stenting predicts the long-term outcomes of obstructive colorectal cancer
Ryuichiro Sato, Masaya Oikawa, Tetsuya Kakita, Takaho Okada, Tomoya Abe, Takashi Yazawa, Haruyuki Tsuchiya, Naoya Akazawa, Masaki Sato, Tetsuya Ohira, Yoshihiro Harada, Haruka Okano, Kei Ito, Noriaki Ohuchi, Takashi Tsuchiya
Surgery Today.2020; 50(3): 232. CrossRef
Prognostic impact of preoperative immunonutritional status in rectal mucinous adenocarcinoma
Yanwu Sun, Zhekun Huang, Huiming Lin, Pan Chi
Future Oncology.2020; 16(8): 339. CrossRef
Low Prognostic Nutritional Index Predicts Poor Clinical Outcomes in Patients with Stage IIIB Non-small-cell Lung Carcinoma Undergoing Chemoradiotherapy

Yurday Ozdemir, Erkan Topkan, Huseyin Mertsoylu, Ugur Selek
Cancer Management and Research.2020; Volume 12: 1959. CrossRef
Peripheral blood markers predictive of outcome and immune-related adverse events in advanced non-small cell lung cancer treated with PD-1 inhibitors
Lihong Peng, Yong Wang, Fen Liu, Xiaotong Qiu, Xinwei Zhang, Chen Fang, Xiaoyin Qian, Yong Li
Cancer Immunology, Immunotherapy.2020; 69(9): 1813. CrossRef
The prognostic value of the prognostic nutritional index and inflammation-based markers in obstructive colorectal cancer
Ryuichiro Sato, Masaya Oikawa, Tetsuya Kakita, Takaho Okada, Tomoya Abe, Takashi Yazawa, Haruyuki Tsuchiya, Naoya Akazawa, Masaki Sato, Tetsuya Ohira, Yoshihiro Harada, Haruka Okano, Kei Ito, Takashi Tsuchiya
Surgery Today.2020; 50(10): 1272. CrossRef
Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy

Siyi Lu, Zhenzhen Liu, Xin Zhou, Bingyan Wang, Fei Li, Yanpeng Ma, Wendong Wang, Junren Ma, Yuxia Wang, Hao Wang, Wei Fu
Cancer Management and Research.2020; Volume 12: 8555. CrossRef
Immunonutritional status and pulmonary cavitation in patients with tuberculosis: A revisit with an assessment of neutrophil/lymphocyte ratio
Makoto Nakao, Hideki Muramatsu, Sosuke Arakawa, Yusuke Sakai, Yuto Suzuki, Kohei Fujita, Hidefumi Sato
Respiratory Investigation.2019; 57(1): 60. CrossRef
Temporal changes in immune cell composition and cytokines in response to chemoradiation in rectal cancer
Yong Joon Lee, Sat Byol Lee, Suk Kyung Beak, Yoon Dae Han, Min Soo Cho, Hyuk Hur, Kang Young Lee, Nam Kyu Kim, Byung Soh Min
Scientific Reports.2018;[Epub] CrossRef
Impairment of Immunonutritional Status During Treatment is a Factor Associated With Oncologic Outcomes in Patients With Rectal Cancer Treated With Preoperative Chemoradiotherapy
In Ja Park
Annals of Coloproctology.2016; 32(6): 201. CrossRef

Case Report

Efficacy of Immunohistochemical Staining in Differentiating a Squamous Cell Carcinoma in Poorly Differentiated Rectal Cancer: Two Case Reports: Sairafi Rami, Yoon Dae Han, Mi Jang, Min Soo Cho, Hyuk Hur, Byung Soh Min, Kang Young Lee, Nam Kyu Kim; Ann Coloproctol. 2016;32(4):150-155. Published online August 31, 2016; DOI: https://doi.org/10.3393/ac.2016.32.4.150

5,942 View
36 Download
1 Web of Science
1 Citations

Abstract PDF

A rectal carcinoma, including primary an adenosquamous and a squamous cell carcinoma (SCC), is a very rare disease, accounting for 0.025% to 0.20% of all large-bowel malignant tumors. Because SCCs have a higher mortality than adenosquamous carcinomas, determining whether the primary rectal cancer exhibits an adenomatous component or a squamous component is important. While differentiating between these 2 components, especially in poorly differentiated rectal cancer, is difficult, specific immunohistochemical stains enable accurate diagnoses. Here, we report the use of immunohistochemical stains to distinguish between the adenomatous and the squamous components in 2 patients with low rectal cancer, a 58-year-old man and a 73-year-old woman, who were initially diagnosed using the histopathologic results for a poorly differentiated carcinoma. These data suggest that using these immunohistochemical stains will help to accurately diagnose the type of rectal cancer, especially for poorly differentiated carcinomas, and will provide important information to determine the proper treatment for the patient.

Citations

Citations to this article as recorded by

Cerebral metastasis from anal squamous cell carcinoma: A case report and literature review
Elena Popa, Vanesa Tomatis, Esther Quick, Paul Mitchell, Chrisovalantis Tsimiklis, Annika Mascarenhas
Oncology Letters.2025; 30(1): 1. CrossRef

Original Articles

The Clinical Features and Predictive Risk Factors for Reoperation in Patients With Perianal Crohn Diseases; A Multi-Center Study of a Korean Inflammatory Bowel Disease Study Group: Jae Bum Lee, Seo-Gue Yoon, Kyu Joo Park, Kang Young Lee, Dae Dong Kim, Sang Nam Yoon, Chang Sik Yu; Ann Coloproctol. 2015;31(5):176-181. Published online October 31, 2015; DOI: https://doi.org/10.3393/ac.2015.31.5.176

3,818 View
62 Download
8 Web of Science
8 Citations

Abstract PDF

Purpose

Perianal lesions are common in Crohn disease, but their clinical course is unpredictable. Nevertheless, predicting the clinical course after surgery for perianal Crohn disease (PCD) is important because repeated operations may decrease patient's quality of life. The aim of this study was to predict the risk of reoperation in patients with PCD.

Methods

From September 1994 to February 2010, 377 patients with PCD were recruited in twelve major tertiary university-affiliated hospitals and two specialized colorectal hospitals in Korea. Data on the patient's demographics, clinical features, and surgical outcomes were analyzed.

Results

Among 377 patients, 227 patients were ultimately included in the study. Among the 227 patients, 64 patients underwent at least one reoperation. The median period of reoperation following the first perianal surgery was 94 months. Overall 3-year, 5-year, and 10-year cumulative rates of reoperation-free individuals were 68.8%, 61.2%, and 50.5%, respectively. In multivariate analysis (Cox-regression hazard model), reoperation was significantly correlated with an age of onset less than 20 years (hazard ratio [HR], 1.93; 95% confidence interval [CI], 1.07-3.48; P = 0.03), history of abdominal surgery (HR, 1.99; 95% CI, 1.08-3.64; P = 0.03), and the type of surgery. Among types of surgery, fistulotomy or fistulectomy was associated with a decreased incidence of reoperation in comparison with incision and drainage (HR, 0.19; 95% CI, 0.09-0.42; P < 0.001).

Conclusion

Young age of onset and a history of abdominal surgery were associated with a high risk of reoperation for PCD, and the risk of reoperation were relatively low in fistulotomy or fistulectomy procedures.

Citations

Citations to this article as recorded by

A nanofiber-hydrogel composite improves tissue repair in a rat model of Crohn’s disease perianal fistulas
Ling Li, Zhi-Cheng Yao, Alyssa Parian, Yueh-Hsun Yang, Jeffrey Chao, Jason Yin, Kevan J. Salimian, Sashank K. Reddy, Atif Zaheer, Susan L. Gearhart, Hai-Quan Mao, Florin M. Selaru
Science Advances.2023;[Epub] CrossRef
Predictors of reoperation for perianal fistula in Crohn's disease
Kwangwoo Nam, Won Beom Jung, Seung Bum Lee, Jae Seung Soh, Song Soo Yang, Seok Won Jung
Journal of Digestive Diseases.2021; 22(6): 334. CrossRef
Perianal and Luminal Relapse Following Perianal Surgical Intervention in Crohn’s Disease
Feihong Deng, Pianpian Xia, Zengrong Wu, Hejun Zhou, Xuehong Wang
International Journal of General Medicine.2021; Volume 14: 3387. CrossRef
Predictors of Perianal Fistula Relapse in Crohn’s Disease
Audrey Malian, Pauline Rivière, Dominique Bouchard, François Pigot, Marianne Eléouet-Kaplan, Charlotte Favreau-Weltzer, Florian Poullenot, David Laharie
Inflammatory Bowel Diseases.2020; 26(6): 926. CrossRef
Predictors of Perianal Fistula Relapse in Crohn’s Disease
Dana J Lukin
Inflammatory Bowel Diseases.2019;[Epub] CrossRef
Management of Perianal Fistulas in Crohn’s Disease
Steffen Seyfried, Alexander Herold
Visceral Medicine.2019; 35(6): 338. CrossRef
Surgical management of fistulating perianal Crohn's disease: a UK survey
M. J. Lee, N. Heywood, P. M. Sagar, S. R. Brown, N. S. Fearnhead
Colorectal Disease.2017; 19(3): 266. CrossRef
Risk of Repeat Surgery for Perianal Crohn Disease
Doo Han Lee
Annals of Coloproctology.2015; 31(5): 169. CrossRef

Feasibility and Safety of a Fold-Over Diverting Ileostomy Reversal After Rectal Cancer Surgery: Case-Matched Comparison to the Resection Technique: Jinock Cheong, Jeonghyun Kang, Im-Kyung Kim, Nam Kyu Kim, Seung-Kook Sohn, Kang Young Lee; Ann Coloproctol. 2014;30(3):118-121. Published online June 23, 2014; DOI: https://doi.org/10.3393/ac.2014.30.3.118

5,044 View
36 Download
7 Web of Science
6 Citations

Abstract PDF

Purpose

Compared to the stapling technique, the fold-over technique (FO) has the benefit of avoiding the sacrifice of the bowel segment. The aim of this study was to compare short-term outcomes between the FO and a conventional resection.

Methods

Between June 2008 and March 2012, a total of 242 patients who underwent a diverting ileostomy reversal after rectal cancer surgery were selected. Among them, 29 patients underwent the FO. Using propensity scores to adjust for body mass index, previous abdominal surgery history, rectal cancer surgery type (open vs. minimally invasive), and reason for ileostomy (protective aim vs. leakage management), we created a well-balanced cohort by matching each patient who underwent the FO, as the study group, with two patients who underwent a stapled or a hand-sewn technique with bowel resection (RE), as the control group (FO : RE = 1 : 2). Morbidity and perioperative recovery were compared between the two groups.

Results

Twenty-four and forty-eight patients were allocated to the FO and the RE groups, respectively. The mean operation time was 91 ± 26 minutes in the FO group and 97 ± 34 minutes in the RE group (P = 0.494). The overall morbidity rates were not different between the two groups (12.5% in FO vs. 14.6% in RE, P = 1.000). The rate of postoperative ileus was similar between the two groups (8.3% in FO vs. 12.5% in RE, P = 0.710). Although time to resumption of soft diet was shorter in the FO group than in the RE group, the lengths of hospital stay were not different.

Conclusion

The FO and the conventional resection have similar short-term clinical outcomes for diverting ileostomy reversal.

Citations

Citations to this article as recorded by

Comparison of hand-sewn anterior repair, resection and hand-sewn anastomosis, resection and stapled anastomosis techniques for the reversal of diverting loop ileostomy after low anterior rectal resection: a randomized clinical trial
Seyed Mostafa Meshkati Yazd, Reza Shahriarirad, Mohammad Reza Keramati, Mehdi Fallahi, Soheila-sadat Nourmohammadi, Alireza Kazemeini, Mohammad Sadegh Fazeli, Amir Keshvari
Techniques in Coloproctology.2024;[Epub] CrossRef
Does the timing of protective ileostomy closure post-low anterior resection have an impact on the outcome? A retrospective study
Fozan Sauri, Ahmad Sakr, Ho Seung Kim, Mohammed Alessa, Radwan Torky, Eman Zakarneh, Seung Yoon Yang, Nam Kyu Kim
Asian Journal of Surgery.2021; 44(1): 374. CrossRef
Modified Colon Leakage Score to Predict Anastomotic Leakage in Patients Who Underwent Left-Sided Colorectal Surgery
Seung Up Yang, Eun Jung Park, Seung Hyuk Baik, Kang Young Lee, Jeonghyun Kang
Journal of Clinical Medicine.2019; 8(9): 1450. CrossRef
Factors affecting the morbidity and mortality of diverting stoma closure: retrospective cohort analysis of twelve-year period
Bojan Krebs, Arpad Ivanecz, Stojan Potrc, Matjaz Horvat
Radiology and Oncology.2019; 53(3): 331. CrossRef
Impact of prior abdominal surgery on postoperative prolonged ileus after ileostomy repair
Im-kyung Kim, Jeonghyun Kang, Seung Hyuk Baik, Kang Young Lee, Nam Kyu Kim, Seung-Kook Sohn
Asian Journal of Surgery.2018; 41(1): 86. CrossRef
Endless Arguments Over Diversion Stomas
Seung Chul Heo
Annals of Coloproctology.2014; 30(3): 103. CrossRef

Case Report

An Extragastrointestinal Stromal Tumor in the Omentum With Peritoneal Seeding Mimicking an Appendiceal Mucinous Cancer With Carcinomatosis: Jeonghyun Kang, Tae Joo Jeon, Sun Och Yoon, Kang Young Lee, Seung-Kook Sohn; Ann Coloproctol. 2014;30(2):93-96. Published online April 25, 2014; DOI: https://doi.org/10.3393/ac.2014.30.2.93

4,761 View
49 Download
4 Web of Science
5 Citations

Abstract PDF

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract. These tumors tend to present most frequently in the stomach, followed by the small intestine. GISTs can also arise from the omentum, retroperitoneum, mesentery, or pleura and are termed extragastrointestinal stromal tumors (EGISTs) when they do so. EGISTs arising from the omentum are very rare. Due to the limited incidence of EGISTs in the omentum, the diagnostic criteria are not well established, and making a correct diagnosis may be difficult. In this report, we present a case of an EGIST of the omentum with peritoneal metastasis that was initially suspected to be an appendiceal mucinous carcinoma with carcinomatosis on positron emission tomography/computed tomography imaging.

Citations

Citations to this article as recorded by

Primary Extragastrointestinal Stromal Tumor of Greater Omentum with Intraperitoneal Bleeding
Masatoshi Kataoka, Tsukasa Saitoh, Kousaku Kawashima, Tomotaka Yazaki, Hiroki Sonoyama, Eiko Okimoto, Akihiko Oka, Yoshiyuki Mishima, Tsuyoshi Mishiro, Naoki Oshima, Kotaro Shibagaki, Hiroshi Tobita, Ichiro Moriyama, Norihisa Ishimura, Mamiko Nagase, Nori
Internal Medicine.2021; 60(21): 3413. CrossRef
Recurrent and metastatic extragastrointestinal stromal tumors of the mesentery with C-KIT and PDGFRA mutations: a case report
Huang Yayu, Zhang Changmao, Dai Yijun, Lin Na, Xu Tianwen, Dai Yangbin
Cancer Biology & Therapy.2020; 21(2): 101. CrossRef
Mucinous Carcinomatosis: A Rare Association between an Ovarian Tumor and an E-GIST
Hugo Palma Rios, André Goulart, Pedro Leão
Case Reports in Surgery.2018; 2018: 1. CrossRef
Extra-gastrointestinal stromal tumour. Report of primary tumour in the omentum
E.N. Valdes-Peregrina, M. Hernández-González, O. de León-Pacheco, S. Mendoza-Ramírez
Revista Médica del Hospital General de México.2018; 81(4): 221. CrossRef
Clinicopathological features and prognosis of omental gastrointestinal stromal tumor: evaluation of a pooled case series
Fan Feng, Yangzi Tian, Zhen Liu, Shushang Liu, Guanghui Xu, Man Guo, Xiao Lian, Daiming Fan, Hongwei Zhang
Scientific Reports.2016;[Epub] CrossRef

Original Article

Risk Factors for Repeat Abdominal Surgery in Korean Patients with Crohn's Disease: A Multi-Center Study of a Korean Inflammatory Bowel Disease Study Group: Kil Yeon Lee, Chang Sik Yu, Kang Young Lee, Yong Beom Cho, Kyu Joo Park, Gyu-Seog Choi, Sang Nam Yoon, Hanna Yoo; J Korean Soc Coloproctol. 2012;28(4):188-194. Published online August 31, 2012; DOI: https://doi.org/10.3393/jksc.2012.28.4.188

3,876 View
24 Download
8 Citations

Abstract PDF

Purpose

The purpose of this study was to assess the risk factors for repeated abdominal surgery in Crohn's disease (CD) patients after the first abdominal surgery. Prior studies have tried to identify the risk factors for postoperative recurrence in CD patients, but the results of the studies have been inconsistent. Furthermore, few data on the risk factors for repeated abdominal surgery are available.

Methods

Clinical data on CD patients who underwent abdominal surgery from January 2000 to December 2009 were collected from seventeen university hospitals and one colorectal clinic. Data from a total of 708 patients were analyzed to find the risk factors for repeated abdominal surgery in CD patients. The mean follow-up period was 72 months.

Results

The risk of repeated abdominal surgery was 3 times higher in young patients (below 16 years old) than in older patients (odds ratio [OR], 3.056; 95% confidence interval [CI], 1.021 to 9.150); P = 0.046). Stricturing behavior at diagnosis was also a risk factor for repeated abdominal surgery (OR, 2.438; 95% CI, 1.144 to 5.196; P = 0.021). Among operative indications, only intra-abdominal abscess was associated with repeated abdominal surgery (OR, 2.393; 95% CI, 1.098 to 5.216; P = 0.028). Concerning type of operation, an ileostomy might be a risk factor for repeated abdominal surgery (OR, 11.437; 95% CI, 1.451 to 90.124; P = 0.021). Emergency surgery (OR, 4.994; 95% CI, 2.123 to 11.745; P < 0.001) and delayed diagnosis after surgery (OR, 2.339; 95% CI, 1.147 to 4.771; P = 0.019) also increased the risk of repeated abdominal surgery.

Conclusion

Young age (below 16 years), stricturing behavior, intra-abdominal abscess, emergency surgery, and delayed diagnosis after surgery were identified as possible risk factors for repeated abdominal surgery in CD patients.

Citations

Citations to this article as recorded by

Therapeutic strategies in Crohn’s disease in an emergency surgical setting
Maria Michela Chiarello, Gilda Pepe, Valeria Fico, Valentina Bianchi, Giuseppe Tropeano, Gaia Altieri, Giuseppe Brisinda
World Journal of Gastroenterology.2022; 28(18): 1902. CrossRef
Risk Factors for Postoperative Recurrence in Korean Patients with Crohn’s Disease
Sung Bae Kim, Jae Hee Cheon, Jae Jun Park, Eun Soo Kim, Seong Woo Jeon, Sung-Ae Jung, Dong Il Park, Chang Kyun Lee, Jong Pil Im, You Sun Kim, Hyun Soo Kim, Jun Lee, Chang Soo Eun, Jeong Mi Lee, Byung Ik Jang, Geom Seog Seo
Gut and Liver.2020; 14(3): 331. CrossRef
Prevalence and factors associated with re-laparotomy among patients operated in Debre-Markos referral hospital, north west Ethiopia: Retrospective cross-sectional study
Yeneabat Birhanu, Debrework Tesgera, Henok Biresaw Netsere, Nurhusien Nuru
International Journal of Africa Nursing Sciences.2020; 13: 100249. CrossRef
Comparison of missing data methods in clustered survival data using Bayesian adaptive B-Spline estimation
Hanna Yoo, Jae Won Lee
Communications for Statistical Applications and Methods.2018; 25(2): 159. CrossRef
Patients with perianal Crohn's disease have poor disease outcomes after primary bowel resection
Yoo Min Han, Ji Won Kim, Seong‐Joon Koh, Byeong Gwan Kim, Kook Lae Lee, Jong Pil Im, Joo Sung Kim, Hyun Chae Jung
Journal of Gastroenterology and Hepatology.2016; 31(8): 1436. CrossRef
The Clinical Features and Predictive Risk Factors for Reoperation in Patients With Perianal Crohn Diseases; A Multi-Center Study of a Korean Inflammatory Bowel Disease Study Group
Jae Bum Lee, Seo-Gue Yoon, Kyu Joo Park, Kang Young Lee, Dae Dong Kim, Sang Nam Yoon, Chang Sik Yu
Annals of Coloproctology.2015; 31(5): 176. CrossRef
Crohn's disease in Korea: past, present, and future
Kang-Moon Lee, Ji Min Lee
The Korean Journal of Internal Medicine.2014; 29(5): 558. CrossRef
Clinical and Endoscopic Recurrence after Surgical Resection in Patients with Crohn's Disease
Yang Woon Lee, Kang-Moon Lee, Woo Chul Chung, Chang Nyol Paik, Hea Jung Sung, You Suk Oh
Intestinal Research.2014; 12(2): 117. CrossRef

Editorial

Early Detection of Colorectal Cancer, Is It a Guarantee for the Cure of Cancer?: Kang Young Lee; J Korean Soc Coloproctol. 2012;28(1):6-6. Published online February 29, 2012; DOI: https://doi.org/10.3393/jksc.2012.28.1.6

2,826 View
22 Download
1 Citations

PDF

Citations

Citations to this article as recorded by

Diminutif ve Küçük Kolorektal Poliplerde Kanser Riskinin Değerlendirilmesi
Nurhan DEMİR
Artuklu International Journal of Health Sciences.2022; 2(3): 20. CrossRef

Original Article

Oncologic Outcomes of a Laparoscopic Right Hemicolectomy for Colon Cancer: Results of a 3-Year Follow-up: Jung Hoon Cho, Dae Ro Lim, Hyuk Hur, Byung Soh Min, Seung Hyuk Baik, Kang Young Lee, Nam Kyu Kim; J Korean Soc Coloproctol. 2012;28(1):42-48. Published online February 29, 2012; DOI: https://doi.org/10.3393/jksc.2012.28.1.42

6,041 View
47 Download
8 Citations

Abstract PDF

Purpose

The purpose of the study is to evaluate the oncologic outcomes of a laparoscopic-assisted right hemicolectomy for the treatment of colon cancer and compare the results with those of previous randomized trials.

Methods

From June 2006, to December 2008, 156 consecutive patients who underwent a laparoscopic right hemicolectomy with a curative intent for colon cancer were evaluated. The clinicopatholgic outcomes and the oncologic outcomes were evaluated retrospectively by using electronic medical records.

Results

There were 84 male patients and 72 female patients. The mean possible length of stay was 7.0 ± 1.5 days (range, 4 to 12 days). The conversion rate was 3.2%. The total number of complications was 30 (19.2%). Anastomotic leakage was not noted. There was no mortality within 30 days. The 3-year overall survival rate of all stages was 93.3%. The 3-year overall survival rates according to stages were 100% in stage I, 97.3% in stage II, and 84.8% in stage III. The 3-year disease-free survival rate of all stages was 86.1%. The 3-year disease-free survival rates according to stage were 96.2% in stage I, 90.3% in stage II, and 75.6% in stage III. The mean follow-up period was 36.3 (3 to 60) months.

Conclusion

A laparoscopic right hemicolectomy for the treatment of colon cancer is technically feasible and safe to perform in terms of oncologic outcomes. The present data support previously reported randomized trials.

Citations

Citations to this article as recorded by

Short-term outcomes and the learning curve for laparoscopic right hemicolectomy using the ArtiSential: a multicenter pooled analysis
Seijong Kim, Jaeim Lee, Heung-Kwon Oh, Dae Hee Pyo, Yoon Suk Lee, Yong Sik Yoon, Dong Hwan Bae, Byung Soh Min, Chang Hyun Kim, Jung Wook Huh
Surgical Endoscopy.2025; 39(5): 2931. CrossRef
Comparison of outcome and costs of robotic and laparoscopic right hemicolectomies
Nima Ahmadi, Isabella Mor, Ross Warner
Journal of Robotic Surgery.2022; 16(2): 429. CrossRef
Is Laparoscopic Complete Mesocolic Excision and Central Vascular Ligation Really Necessary for All Patients With Right-Sided Colon Cancer?
Gyung Mo Son, In Young Lee, Yoon Suk Lee, Bong-Hyeon Kye, Hyeon-Min Cho, Je-Ho Jang, Chang-Nam Kim, Kil Yeon Lee, Suk-Hwan Lee, Jun-Gi Kim
Annals of Coloproctology.2021; 37(6): 434. CrossRef
Oncologic Outcomes of Self-Expandable Metallic Stent as a Bridge to Surgery and Safety and Feasibility of Minimally Invasive Surgery for Acute Malignant Colonic Obstruction
Seung Yoon Yang, Youn Young Park, Yoon Dae Han, Min Soo Cho, Hyuk Hur, Byung Soh Min, Kang Young Lee, Nam Kyu Kim
Annals of Surgical Oncology.2019; 26(9): 2787. CrossRef
Comparison of open, laparoscopic, and robotic approaches for total abdominal colectomy
Zhobin Moghadamyeghaneh, Mark H. Hanna, Joseph C. Carmichael, Alessio Pigazzi, Michael J. Stamos, Steven Mills
Surgical Endoscopy.2016; 30(7): 2792. CrossRef
Preoperative prediction of conversion from laparoscopic rectal resection to open surgery: a clinical study of conversion scoring of laparoscopic rectal resection to open surgery
Guang-Dong Zhang, Xu-Ting Zhi, Jian-Li Zhang, Guang-Bo Bu, Gang Ma, Kai-Lei Wang
International Journal of Colorectal Disease.2015; 30(9): 1209. CrossRef
Feasibility and safety of laparoscopic resection following stent insertion for obstructing left-sided colon cancer
Seoung Yoon Rho, Sung Uk Bae, Se Jin Baek, Hyuk Hur, Byung Soh Min, Seung Hyuk Baik, Kang Young Lee, Nam Kyu Kim
Journal of the Korean Surgical Society.2013; 85(6): 290. CrossRef
Totally Laparoscopic Right Hemicolectomy with Intracorporeal Anastomosis is a Technically and Oncologically Safe Procedure
V. N. N. Kornmann, J. Hagendoorn, S.van Koeverden, B.van Ramshorst, A. B. Smits
Acta Chirurgica Belgica.2013; 113(6): 439. CrossRef

First
Prev
Page of 2
Next
Last

Search